Brief: Treace Receives FDA 510(K) Clearance For Speedplate™ Rapid Compression Implant Technology
28/11/2022 21:22
Nov 28 (Reuters) - Treace Medical Concepts Inc TMCI.O :
* TREACE RECEIVES FDA 510(K) CLEARANCE FOR SPEEDPLATE™ RAPID
COMPRESSION IMPLANT TECHNOLOGY
* EXPECTS LIMITED RELEASE OF SPEEDPLATE IMPLANTS WITH
MICRO-LAPIPLASTY INSTRUMENTATION IN H1 OF 2023 WITH EXPANDED
ACCESS IN H2 OF 2023
Source text for Eikon: ID:nGNXb1kvsQ
Further company coverage: TMCI.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Treace Medical Concepts
See all newsTreace Medical Q3 revenue falls but slightly beats expectations
Brief: Treace Medical Q3 EPS USD -0.19
Treace Medical Concepts, Inc. reports results for the quarter ended June 30 - Earnings Summary
Treace Medical Q2 revenue tops estimates on higher surgeon adoption; ups outlook
Treace Medical Concepts, Inc. expected to post a loss of 30 cents a share - Earnings Preview